Table 3 Analysis of DCC expression in node-negative and node-positve cases and in the 31 cases with lymphnodal involvment (N1 vs N2)
| Â | DCC positive | DCC negative |
|---|---|---|
Node negative | 45 (48%) | 18 (19%) |
Node positive | 13 (14%) | 18 (19%) |
pT1-3N1 | 10 (32%) | 5 (16%) |
pT1-3N2 | 3 (10%) | 13 (42%) |